Walden Group Healthcare M&A Blog

  • Celgene to Sell Blockbuster Drug to Amgen for $13.4b

    08/26/2019
    Amgen Inc., a $23b multinational biopharmaceutical company is buying the worldwide rights to Otezla® from Celgene Corporation, a $13b developer of therapies for cancer and inflammatory diseases, for $13.4b. The acquisition complements Amgen's existing inflammation franchise of innovative biologics and biosimilar products. Otezla® (apremilast) is...
    Read More
  • Exact Sciences to buy Genomic Health for $2.8b

    7/29/2019
    Exact Sciences Corp, a $454m molecular diagnostics company is acquiring Genomic Health Inc, a $394m cancer detection company for $2.8b. The deal joins two of the strong brands in molecular and cancer diagnostics, Cologuard® and Oncotype DX®, providing a strong platform for continued growth; and forms a first class commercial, research,...
    Read More
  • Cantel Medical to Acquire Hu-Friedy for $725m

    07/30/2019
    Cantel Medical Corp., a $880m manufacturer of medical equipment announced plans to buy Hu-Friedy Mfg. Co., a maker of dental instruments and reprocessing equipment for $725m. The deal helps build out a portfolio of infection prevention solutions including consumables, instrumentation and workflow management programs for dental practitioners while...
    Read More
  • AbbVie to Buy Allergan for $63b

    06/25/2019
    AbbVie Inc., a $32.75b pharmaceutical company agreed to buy Allergan plc, an Ireland-based $15.79b pharmaceutical company for $63b. The latest merger in an industry where huge premiums are being paid to incease growth prospects. The deal gives AbbVie Botox, but doesn’t involve a huge pipeline of blockbuster drugs. Allergan does diversify AbbVie...
    Read More
  • The Walden Group advises Riverpoint Medical, LLC in its Partnership with Arlington Capital Partners and Helps Guide the Transaction to a Successful Closing

    6/27/2019
    The Walden Group, Inc. is pleased to announce that Arlington Capital Partners has acquired a majority interest in its client, Riverpoint Medical, LLC. Riverpoint is a major developer and manufacturer of advanced bioabsorbable and non-absorbable sutures; high-strength fiber implantables for sports medicine surgery; patented cordless surgeon...
    Read More